Natera

YTD

ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).

CEO

Stephen Leonard Chapman

CEOStephen Leonard Chapman

Employees

6,140

Employees6,140

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2003

Founded2003

Employees

6,140

Employees6,140

NTRA Key Statistics

Market cap

29.42B

Market cap29.42B

Price-Earnings ratio

-133.68

Price-Earnings ratio-133.68

Dividend yield

—

Dividend yield—

Average volume

1.46M

Average volume1.46M

High today

$209.33

High today$209.33

Low today

$203.86

Low today$203.86

Open price

$207.41

Open price$207.41

Volume

986.17K

Volume986.17K

52 Week high

$256.36

52 Week high$256.36

52 Week low

$131.81

52 Week low$131.81

Stock Snapshot

The current Natera(NTRA) stock price is $207.78, with a market capitalization of 29.42B. The stock trades at a price-to-earnings (P/E) ratio of -133.68.

On 2026-04-22, Natera(NTRA) stock traded between a low of $203.86 and a high of $209.33. Shares are currently priced at $207.78, which is +1.9% above the low and -0.7% below the high.

Natera(NTRA) shares are trading with a volume of 986.17K, against a daily average of 1.46M.

During the past year, Natera(NTRA) stock moved between $131.81 at its lowest and $256.36 at its peak.

NTRA News

Simply Wall St 5h

Is It Too Late To Consider Natera After Its Recent Share Price Surge?

For investors considering whether Natera at around US$205 per share still offers value, or whether the recent run has already priced in the story, this article...

TipRanks 9h

Natera announces evidence for Prospera test at 2026 ISHLT

Natera (NTRA) announced a broad body of evidence supporting its Prospera test at the 2026 International Society for Heart and Lung Transplantation, ISHLT, Annua...

TipRanks 5d

Spotify, Sandisk, Natera, Biogen, Tesla Trending With Analysts

Analysts are intrested in these 5 stocks: ( (SPOT) ), ( (SNDK) ), ( (NTRA) ), ( (BIIB) ) and ( (TSLA) ). Here is a breakdown of their recent ratings and the rat...

Analyst ratings

90%

of 21 ratings

Buy

90.5%

Hold

9.5%

Sell

More NTRA News

Simply Wall St 5d

Class Action Certification and CLARITY MRD Data Might Change The Case For Investing In Natera

In April 2026, law firms Kessler Topaz Meltzer & Check and Bernstein Litowitz Berger & Grossmann announced that a securities case against Natera and certain off...

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Fluor

Flowserve

iShares MSCI Emerging Mar…

KLA

ResMed

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.